Dear participants!

Cells built to cure serves as the guiding slogan of the Leibniz Institute for Immunotherapy and captures our enthusiasm for the field of synthetic immunology and synthetic biology. During our conference, leading international experts in this field will present and discuss cutting‑edge, novel approaches.

While genetic reprogramming has been confined to the laboratory, new methods now enable it to be performed directly in the human body – the next major step towards broadly applicable and affordable therapies with gene-engineered immune cells.

Despite significant successes, many fundamental questions remain, and we still need to investigate basic research aspects. Our program, therefore, covers a broad range of challenges from discovery to translation to clinical application. Research topics cover in vivo gene engineering, synthetic cells, organelle medicine and artificial protein design. We will also hear about the most innovative approaches in engineering T-cell fitness in situ, about on-target inducible payloads, and CAR T cells for autoimmune disorders.

Our International LIT Symposium 2026 brings together top experts to explore diverse facets of cellular therapies, offering cutting-edge insights and ample opportunity to debate and develop new ideas in a think-tank setting.

We look forward to welcoming you to the beautiful city of Regensburg for two exciting days!

On behalf of the Board of Directors,

Philipp Beckhove

Conference Chair